I. Talking about Tobacco: Modern approaches to nicotine addiction
Smoking-related deaths are greater than from all other SUDs combined, and tobacco use disorder (TUD) is very common among persons with other SUDs. But unfortunately, TUD is rarely addressed in standard addiction treatment, because of misconceptions that it may be “too much” at once, and a misplaced sense of futility. This workshop will explore these barriers to treatment of TUD and approaches to overcoming them, including: evidence for addressing TUD during treatment for other SUDs, updates on the latest developments in TUD medication treatment, introduction to and early experience with “Talking About Tobacco” a novel motivational intervention for TUD in inpatient SUD settings.
George Kolodner, MD
Clinical Professor of Psychiatry
Georgetown University School of Medicine
George Kolodner, MD has been working to improve access to effective treatment for people with alcohol and drug problems since 1973, when he established the first outpatient addiction rehabilitation treatment program. That model, now called “intensive outpatient” or “IOP,” has become a cornerstone of current addiction treatment in this country. Now extending this work with a focus on addiction to nicotine, he has designed an innovative treatment program that builds on traditional methods of addressing other addictive substances. Dr. Kolodner has been active in professional organizations and was recently appointed the Chair of the Nicotine and Tobacco Special Interest Group of the American Society of Addiction Medicine. He is also a Clinical Professor of Psychiatry at both Georgetown University and University of Maryland Schools of Medicine.
Marc Fishman, MD
Addiction Psychiatrist
Maryland Treatment Centers, Mountain Manor
Marc Fishman, MD is an addiction psychiatrist, and leads Maryland Treatment Centers / Mountain Manor, a regional behavioral healthcare provider, which offers programs for residential and outpatient SUD and co-occurring treatment for youth and adults. He is a member of the psychiatry faculty at Johns Hopkins University School of Medicine. His academic and research work has focused on addiction pharmacotherapy; models of care for youth, particularly with OUD; and treatment placement and matching strategies.
Dr. Fishman served as a co-editor for the most recent editions of the ASAM Criteria for the Treatment of Substance-Related Disorders. He served as a past President of the Maryland Society of Addiction Medicine, and is a current member of its Board.